In addition, Mo-TAMs expressed SIRPA and showed a selective upregulation of PD1 and leukocyte immunoglobulin-like receptor LILRB1 (Figure 2D), two additional inhibitory receptors impairing macrophage-dependent clearance of cancer cells. This evidence concerns the gene SIRPA and cancer.